Skip to main content
. 2012 Nov 14;7(11):e49032. doi: 10.1371/journal.pone.0049032

Table 2. Stratification analyses of genetic susceptibility of rs11614913 polymorphism to cancer risk.

Category Cases/Controls TT vs. CC CT vs. CC TT+CT vs. CC TT vs. CC+CT
OR(95% CI) P a I 2 OR(95% CI) P a I 2 OR (95% CI) P a I 2 OR(95% CI) P a I 2
Total 12663/14739 0.83(0.74,0.93) b 0.001 52.5 0.98(0.90,1.07)b 0.004 47.5 0.94(0.86,1.02)b 0.001 53.8 0.86(0.79,0.95) b 0.005 46.7
Cancer types
Breast cancer 3722/4712 0.81(0.61,1.09)b 0.014 68 0.94(0.85,1.04) 0.532 0 0.91(0.83,1.00) 0.148 41 0.87(0.70,1.08)b 0.027 63.5
Colorectal cancer 1397/2040 0.70(0.57,0.85) 0.284 21.1 0.81(0.65,1.08) 0.367 5.2 0.77(0.65,0.91) 0.377 3.1 0.80(0.69,0.94) 0.198 35.7
HCC 1015/999 0.74(0.47,1.19)b 0.022 69 0.90(0.72,1.11) 0.631 0 0.85(0.69,1.04) 0.19 37 0.18(0.57,1.15)b 0.037 64.6
Lung cancer 2118/2103 0.77(0.65,0.91) 0.895 0 0.90(0.77,1.04) 0.098 57 0.85(0.74,0.98) 0.289 19.4 0.83(0.73,0.95) 0.281 21.3
Gastric cancer 765/910 0.80(0.61,1.06) 0.306 4.5 0.84(0.65,1.08) 0.163 48.5 0.82(0.65,1.04) 0.162 48.8 0.89(0.72,1.11) 0.698 0
Other cancers 3646/3975 1.06 (0.91,1.23) 0.125 38.2 1.23(1.10,1.37) 0.239 23.9 1.13(1.03,1.25) 0.096 40.7 0.93(0.74,1.17) 0.024 56.7
Ethnicities
Asian 7837/8878 0.80(0.73,0.88) 0.169 23.7 0.99(0.88,1.13)b 0.001 57.4 0.95(0.84,1.07)b 0.001 58.3 0.85(0.80,0.92) 0.3 12.6
Caucasian 4400/5395 0.94(0.71,1.23)b 0.006 69.7 1.01(0.92,1.04)b 0.597 0 0.98(0.90,1.07) 0.181 32.3 0.94(0.74,1.21)b 0.005 70.5
Source of controls
Population based 11123/12811 0.87(0.77,0.98) b 0.009 46.7 1.01(0.91,1.11)b 0.002 52.4 0.97(0.88,1.06)b 0.001 54.8 0.89(0.82,0.98) b 0.024 41.1
Hospital based 1540/1928 0.65(0.53,0.79) 0.111 50 0.85(0.72,1.01) 0.868 0 0.78 (0.67,0.92) 0.585 0 0.74(0.63,0.87) 0.092 53.5
a

P value of Q-test for heterogeneity test.

b

Random-effects model was used when a P value<0.05 for heterogeneity test; otherwise, fixed-effects model was used.

I 2: 0–25, no heterogeneity; 25–50, modest heterogeneity; 50, high heterogeneity.